8-K - Turn Therapeutics Inc. (0002023016) (Filer)
Published . Updated .
Filed: 2026-10-07 AccNo: 0001213900-26-107329 Size: 23 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Directly affected
- TTRX Turn Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-07 AccNo: 0001213900-26-107329 Size: 23 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Turn Therapeutics (TTRX)
Since the first closing price after “8-K - Turn Therapeutics Inc. (0002023016) (Filer),” Turn Therapeutics (TTRX) is -6.46%. The S&P 500 fund (SPY) is -0.94% over the same days, a -5.52% difference versus the market.
Who is named in “8-K - Turn Therapeutics Inc. (0002023016) (Filer)”
Companies mentioned with this story
- TTRX Turn Therapeutics
In “8-K - Turn Therapeutics Inc. (0002023016) (Filer),” Turn Therapeutics (TTRX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> TTRX
How “8-K - Turn Therapeutics Inc. (0002023016) (Filer)” reaches Turn Therapeutics (TTRX)
Turn Therapeutics (TTRX) is the company in “8-K - Turn Therapeutics Inc. (0002023016) (Filer),” the 7 Oct 2026 this story story.
What ties Turn Therapeutics (TTRX) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> TTRX
Dates in the story, and the Turn Therapeutics (TTRX) price range
TTRX traded between 10.26 and 15.40 across 20 sessions. The latest close on file is 10.72.
A simple score for Turn Therapeutics (TTRX)
14 out of 100
“8-K - Turn Therapeutics Inc. (0002023016) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.